From the Department for Diseases of the Chest, Jefferson Hospital, Philadelphia, and the White Haven Sanatorium, White Haven, Pennsylvania. Read before the Harvard Medical Society, Boston, Mass ...

They may also help to identify mechanisms responsible for lung destruction in COPD, which in turn could identify new treatment targets that bronchodilators – although a mainstay of therapy ...

exploring the biological mechanisms behind these benefits, and assessing the long-term impact of these medications on COPD progression,” he added. MNT had the opportunity to speak with Fady ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

The precise mechanism through which fluticasone furoate affects COPD and asthma symptoms is not known. Corticosteroids have been shown to have a wide range of actions on multiple cell types (eg ...